Global Biotech: Clinical Trials

1 trial sponsored by Global Biotech, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow Global Biotech: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety Study of a Recombinant Human Plasminogen Activator to Treat Acute Ischemic Stroke.
Recombinant Human Plasminogen Activator (HTUPA) - Cerebrovascular Accident
Phase 1 / Phase 2CompletedGlobal Biotech302001-04-012007-01-04

Conditions studied

Stroke (1)

Countries

Taiwan (1)

Top investigators

Han-Hwa Hu, M.D. (1)

Results publications

PMID 16424373